Managing therapy delivery based on physiological markers

A system comprising:

• one or more processors configured to:
• monitor a fill cycle of a bladder of a patient;
• determine, based on one or more physiological markers associated with the fill cycle, a first phase including and following a start of the fill cycle and a second phase of the fill cycle immediately following the first phase, wherein the second phase is determined to include delivery of neurostimulation therapy configured to inhibit contraction of a bladder of the patient;
• and
• control a medical device to deliver the neurostimulation therapy to the patient during the second phase of the fill cycle.

A method comprising:

• monitoring, by one or more processors, a fill cycle of a bladder of a patient;
• determining, by the one or more processors and based on one or more physiological markers associated with the fill cycle, a first phase including and following the start of the fill cycle and a second phase of the fill cycle immediately following the first phase, wherein the second phase is determined to include delivery of neurostimulation therapy configured to inhibit contraction of a bladder of the patient;
• and
• controlling, by the one or more processors, a medical device to withhold delivery of all neurostimulation therapy to the patient for the first phase of the fill cycle.

A system comprising:

• one or more processors configured to:
• monitor a fill cycle of a bladder of a patient;
• determine, based on one or more physiological markers associated with the fill cycle, a first phase including and following a start of the fill cycle and a second phase of the fill cycle immediately following the first phase, wherein the second phase is determined to include delivery of neurostimulation therapy configured to inhibit contraction of a bladder of the patient;
• and
• control a medical device to withhold delivery of all neurostimulation therapy to the patient for the first phase of the fill cycle.